Search

everythinglearnresearchcommunity

for

Search:↓

Nivolumab can cause hair loss as a rare side effect.

Preventive measures and effective management are crucial for reducing skin side effects in cancer treatment.

Ablative fractional laser treatment nearly matches the gene reduction effects of topical vismodegib in skin cancer.

Targeted cancer therapies often cause skin side effects, needing dermatologist care.

A botanical extract may help manage hair loss from chemotherapy by preventing cell death in hair follicles.

M30 is a promising treatment for preventing hair loss during chemotherapy.

A woman with severe angioedema improved significantly after treatment with rituximab.

EGFR inhibitors for lung cancer can cause severe skin issues.

A scalp-cooling system effectively prevents hair loss in breast cancer patients treated with eribulin.

PRIDE complex side effects from EGFR inhibitors can be managed without stopping treatment.

Scalp cooling is an effective and safe way to prevent hair loss from chemotherapy, with manageable side effects and low risk of scalp cancer.

CDK4/6 inhibitors affect safety and quality of life differently, requiring careful use.

Scalp cooling helps prevent hair loss during chemotherapy for breast cancer.

A woman's pelvic pain and bleeding led to finding and successfully treating a rare benign tumor in her reproductive system.

Chemotherapy can cause various skin problems, and recognizing them helps improve patient care.

Early diagnosis and treatment of EGFR inhibitor-induced folliculitis decalvans can prevent permanent hair loss.

Medicines for enlarged prostate may raise the risk of breast growth and tenderness but not breast cancer.

Combining dutasteride mesotherapy with oral minoxidil is more effective for hair loss than using oral minoxidil alone.

Rapid virilization should be checked for possible ovarian or adrenal cancer.

Pegylated liposomal doxorubicin is as effective as conventional doxorubicin but causes fewer heart problems and side effects.

Intralesional steroids are more effective for hair regrowth in alopecia areata than NBUVB, but combining them doesn't improve results.

Most patients experienced mild to moderate skin problems during a trial for a desmoid tumor treatment.

Thorough evaluations and conservative management can lead to positive outcomes in pediatric adrenocortical carcinoma.

Chemotherapy can cause significant but usually reversible hair loss, and managing it involves patient education and hair care strategies.

Oophorectomy reduces ovarian cancer risk for women with BRCA mutations, finasteride lowers prostate cancer risk without raising death risk, and prophylactic mastectomy rates are rising.

Chemotherapy caused hair loss with specific patterns, but most patients had hair regrowth after treatment, while some had lasting hair loss.

Adalimumab was safe but mostly ineffective for severe alopecia areata.

Combined BRAF and MEK treatment increases rash risk but reduces other skin issues compared to BRAF alone.

A woman's Cushing's syndrome caused by adrenal cancer improved after surgery.

Preventing cancer involves lifestyle changes, vaccinations, early screening, and understanding cancer's molecular basis.